Affinivax Announces $120 Million Series B Financing to Advance Pipeline of Novel MAPS Vaccines and Immunotherapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2KtvqMV
via IFTTT